SS Innovations Reports Record Q2 Revenue, Highlighting Global Expansion of SSi Mantra Robotic Surgery Platform

SS Innovations International Inc. (NASDAQ: SSII) has reported record second-quarter revenue of $13.9 million, a 39.4% increase from $10.0 million in the same period last year, signaling continued momentum for its SSi Mantra surgical robotic platform. The company's first-half revenue reached $25.0 million, up 65.6% from $15.1 million in the prior year, with gross profit rising 77.5% to $12.4 million during the same period (https://nnw.fm/zxrT1).

The revenue growth is driven by an expanding installed base of SSi Mantra systems, which increased by 30.4% to 30 systems during the quarter. As of the end of Q2, the installed base stood at 224 systems across 12 countries, with a cumulative 12,272 surgeries performed. This expansion highlights the platform's growing acceptance in diverse healthcare markets and its role in advancing minimally invasive surgery.

The company's telesurgery achievements are extending the clinical profile of SSi Mantra, demonstrating its capability to enable remote surgical procedures, which is particularly valuable in underserved regions. However, system installations remain the primary commercial growth driver, reflecting a robust demand for robotic-assisted surgery solutions that improve patient outcomes and operational efficiency.

Looking ahead, regulatory milestones in the U.S. and Europe could serve as significant catalysts. The company is targeting FDA clearance by the first quarter of 2027 and EU CE marking by the end of 2026. These approvals would open access to two of the world's largest medical device markets, potentially accelerating adoption and revenue growth. The company's progress in these regulatory processes is closely watched by investors and healthcare providers alike.

The strong financial performance and strategic focus on regulatory advancement underscore SS Innovations' position in the competitive surgical robotics market. With a growing installed base and a clear path to key market approvals, the company is well-positioned to capitalize on the increasing demand for robotic surgery technologies. As the healthcare industry continues to embrace automation and precision, SSi Mantra's success could have broader implications for surgical care delivery globally.